CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 US$ 24.93 Min. order: 1 piece ★★★★★ 4.6 (162 reviews) Sold : Login>>
Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept - Bhattachar - 2026 - Diabetes, Obesity and Metabolism US$ 26.16 Min. order: 1 piece ★★★★★ 4.1 (138 reviews) Sold : Login>>
Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review US$ 22.48 Min. order: 1 piece ★★★★★ 4.0 (182 reviews) Sold : Login>>
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit US$ 22.14 Min. order: 1 piece ★★★★★ 4.6 (253 reviews) Sold : Login>>
Cagrilintide: The Next-Gen Peptide for Weight Loss and Satiety US$ 23.01 Min. order: 1 piece ★★★★★ 4.0 (80 reviews) Sold : Login>>